BRITTANY AMATO: Open Payments
NPI 1740768191 · NORTH MASSAPEQUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,448 in 116 payments from 24 companies in 2025. Trend: 2023 $707 · 2024 $2,718 · 2025 $2,448
Food & beverage: $2,448
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $307 |
| Lundbeck LLC | 18 | $270 |
| Lilly USA, LLC | 13 | $236 |
| GlaxoSmithKline, LLC. | 9 | $210 |
| Astellas Pharma US Inc | 8 | $195 |
| ABBVIE INC. | 10 | $191 |
| Amgen Inc. | 11 | $176 |
| Xeris Pharmaceuticals, Inc. | 8 | $163 |
| Renalytix AI, Inc. | 5 | $109 |
| Esperion Therapeutics, Inc. | 4 | $82 |
Products named: REXULTI, TRELEGY ELLIPTA, AIRSUPRA, Veozah, OTEZLA, RECORLEV, MOUNJARO, UBRELVY.
Industry payments across NY — which companies pay providers there.
